D-1869-2019 Class II Terminated
FDA drug recall D-1869-2019 was initiated by Aurolife Pharma, LLC on August 23, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated August 16, 2022). Affected quantity: 129,600 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- September 25, 2019
- Initiation Date
- August 23, 2019
- Termination Date
- August 16, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 129,600 cartons
Product Description
Allergy Relief (Fexofenadine HCl) tablets USP, 180 mg, 15-count cartons, equate, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-995-62.
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Nationwide in the USA
Code Information
Lot #s: 067180010A, Exp 03/21; 067180023C1, 067180024D1, Exp 07/21